Announcement of Meetings of the Tick-Borne Disease Working Group, 55845 [2017-25425]

Download as PDF Federal Register / Vol. 82, No. 225 / Friday, November 24, 2017 / Notices Availability of Materials: We will post all meeting materials prior to the meeting on the NPRSB December 7, 2017, meeting Web site located at https://www.phe.gov/nprsb. Procedures for Providing Public Input: Members of the public attend by teleconference via a toll-free call-in phone number, which is available on the NPRSB Web site at https:// www.phe.gov/nprsb. We encourage members of the public to provide written comments that are relevant to the NPRSB teleconference prior to December 7, 2017. Send written comments by email to nprsb@hhs.gov with ‘‘NPRSB Public Comment’’ in the subject line. The NPRSB Chair will respond to all comments received by December 1, 2017, during the meeting. Dated: November 15, 2017. Robert P. Kadlec, Assistant Secretary for Preparedness and Response, Department of Health and Human Services. [FR Doc. 2017–25336 Filed 11–22–17; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Announcement of Meetings of the Tick-Borne Disease Working Group Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: The Department of Health and Human Services (HHS), in accordance with Section 2062 of the 21st Century Cures Act, announces the inaugural meetings of the Tick-Borne Disease Working Group (Working Group). For these first meetings, Working Group members will focus on plans to submit a report to the Secretary of HHS and Congress that is due December 2018. The report will address a number of issues related to tick-borne diseases, including: Ongoing research; advances in research; Federal activities; gaps in research; the Working Group’s meetings; and the comments received by the Working Group. The report will also include any recommendations to the Secretary of Health and Human Services. Planning will include developing plans to solicit stakeholder input and establish subcommittees. Working Group members will also determine how and when future meetings will be conducted. DATES: December 11, 2017, from 12:30 p.m. to 4:30 p.m., Eastern Time, and sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:19 Nov 22, 2017 Jkt 244001 December 12, 2017 from 9:00 a.m. to 4:30 p.m., Eastern Time. ADDRESSES: Hubert H. Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, DC 20201; via webcast at: https://www.hhs.gov/ ash/advisory-committees/tickborne disease/index.html. FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services; via email at tickbornedisease@ hhs.gov. SUPPLEMENTARY INFORMATION: Members of the public may attend the meetings in person or via webcast at https:// www.hhs.gov/ash/advisory-committees/ tickbornedisease/index.html. In-person attendance at the meetings is limited to space available; therefore preregistration for public members is advisable and can be accomplished by registering at http://events.r20.constant contact.com/register/event?llr= zz7zptzab&oeidk=a07edrodfu088eae0cf by Friday, December 8, 2017. On the day of the meetings, seating will be provided first to persons who have preregistered. People who have not preregistered will be accommodated on a first come, first served basis if additional seats are still available 10 minutes before the meetings start. NonU.S. citizens who plan to attend in person are required to provide additional information and must notify the Working Group support staff via email at tickbornedisease@hhs.gov before November 30, 2017. Members of the public who wish to attend the meetings should enter from Independence Avenue. Please allow extra time to get through security. The Working Group invites public comment on issues related to the Working Group’s charge. It may be provided in-person at the meetings or in writing. Persons who wish to provide public comment in person should submit a request to do so via email at tickbornedisease@hhs.gov on or before December 1, 2017. In-person comments will be limited to three minutes each to accommodate as many speakers as possible. A total of 60 minutes will be allocated to public comment and may be divided between the two days of meetings. If more requests are received than can be accommodated, speakers will be randomly selected. The nature of the comments will not be considered in making this selection. Public comment may also be provided in writing only. Individuals who would like to provide written public comment should send their comments to PO 00000 Frm 00047 Fmt 4703 Sfmt 9990 55845 tickbornedisease@hhs.gov on or before December 6, 2017. Meeting information is available at the group’s Web page: https:// www.hhs.gov/ash/advisory-committees/ tickbornedisease/index.html or by contacting the Working Group via email at tickbornedisease@hhs.gov to request additional information. Purpose of Meetings: Working Group members will focus on plans to submit a report to the Secretary of HHS and Congress that is due December 2018. The report will address a number of issues related to tick-borne diseases, including: Ongoing research; advances in research; Federal activities; gaps in research; the Working Group’s meetings; and the comments received by the Working Group. The report will also include any recommendations to the Secretary of Health and Human Services. Planning will include developing plans to solicit stakeholder input and establish subcommittees. Working Group members will also determine how and when future meetings will be conducted. Background and Authority: The TickBorne Disease Working Group was established on August 10, 2017, in accordance with Section 2062 of the 21st Century Cures Act, and the Federal Advisory Committee Act, 5 U.S.C. App., as amended, to provide expertise and review all HHS efforts related to tickborne diseases to help ensure interagency coordination and minimize overlap, examine research priorities, and identify and address unmet needs. The Working Group will submit a report to the Secretary of HHS and Congress on issues related to tick-borne diseases, including: Ongoing research: Advances in research: Federal activities; gaps in research; the Working Group’s meetings; and the comments by the Working Group. Structure, Membership, and Operation: The Working Group consists of 14 members selected to represent a diverse range of stakeholder perspectives. Seven members were nominated and selected from the public, and seven members, or their designees, represent federal agencies doing this work. A roster of Working Group members is available at the Working Group’s Web page: https:// www.hhs.gov/ash/advisory-committees/ tickbornedisease/index.html. Dated: November 15, 2017. Richard Wolitski, Director, Office of HIV/AIDS and Infectious Disease Policy, Designated Federal Officer, Tick-Borne Disease Working Group. [FR Doc. 2017–25425 Filed 11–22–17; 8:45 am] BILLING CODE 4150–28–P E:\FR\FM\24NON1.SGM 24NON1

Agencies

[Federal Register Volume 82, Number 225 (Friday, November 24, 2017)]
[Notices]
[Page 55845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-25425]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Announcement of Meetings of the Tick-Borne Disease Working Group

AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS), in 
accordance with Section 2062 of the 21st Century Cures Act, announces 
the inaugural meetings of the Tick-Borne Disease Working Group (Working 
Group). For these first meetings, Working Group members will focus on 
plans to submit a report to the Secretary of HHS and Congress that is 
due December 2018. The report will address a number of issues related 
to tick-borne diseases, including: Ongoing research; advances in 
research; Federal activities; gaps in research; the Working Group's 
meetings; and the comments received by the Working Group. The report 
will also include any recommendations to the Secretary of Health and 
Human Services. Planning will include developing plans to solicit 
stakeholder input and establish subcommittees. Working Group members 
will also determine how and when future meetings will be conducted.

DATES: December 11, 2017, from 12:30 p.m. to 4:30 p.m., Eastern Time, 
and December 12, 2017 from 9:00 a.m. to 4:30 p.m., Eastern Time.

ADDRESSES: Hubert H. Humphrey Building, Great Hall, 200 Independence 
Avenue SW., Washington, DC 20201; via webcast at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/index.html.

FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and 
Infectious Disease Policy, Office of the Assistant Secretary for 
Health, Department of Health and Human Services; via email at 
tickbornedisease@hhs.gov.

SUPPLEMENTARY INFORMATION: Members of the public may attend the 
meetings in person or via webcast at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/index.html.
    In-person attendance at the meetings is limited to space available; 
therefore preregistration for public members is advisable and can be 
accomplished by registering at http://events.r20.constantcontact.com/register/event?llr=zz7zptzab&oeidk=a07edrodfu088eae0cf by Friday, 
December 8, 2017. On the day of the meetings, seating will be provided 
first to persons who have preregistered. People who have not 
preregistered will be accommodated on a first come, first served basis 
if additional seats are still available 10 minutes before the meetings 
start. Non-U.S. citizens who plan to attend in person are required to 
provide additional information and must notify the Working Group 
support staff via email at tickbornedisease@hhs.gov before November 30, 
2017. Members of the public who wish to attend the meetings should 
enter from Independence Avenue. Please allow extra time to get through 
security.
    The Working Group invites public comment on issues related to the 
Working Group's charge. It may be provided in-person at the meetings or 
in writing. Persons who wish to provide public comment in person should 
submit a request to do so via email at tickbornedisease@hhs.gov on or 
before December 1, 2017. In-person comments will be limited to three 
minutes each to accommodate as many speakers as possible. A total of 60 
minutes will be allocated to public comment and may be divided between 
the two days of meetings. If more requests are received than can be 
accommodated, speakers will be randomly selected. The nature of the 
comments will not be considered in making this selection.
    Public comment may also be provided in writing only. Individuals 
who would like to provide written public comment should send their 
comments to tickbornedisease@hhs.gov on or before December 6, 2017.
    Meeting information is available at the group's Web page: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/index.html or by 
contacting the Working Group via email at tickbornedisease@hhs.gov to 
request additional information.
    Purpose of Meetings: Working Group members will focus on plans to 
submit a report to the Secretary of HHS and Congress that is due 
December 2018. The report will address a number of issues related to 
tick-borne diseases, including: Ongoing research; advances in research; 
Federal activities; gaps in research; the Working Group's meetings; and 
the comments received by the Working Group. The report will also 
include any recommendations to the Secretary of Health and Human 
Services. Planning will include developing plans to solicit stakeholder 
input and establish subcommittees. Working Group members will also 
determine how and when future meetings will be conducted.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with Section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review all HHS 
efforts related to tick-borne diseases to help ensure interagency 
coordination and minimize overlap, examine research priorities, and 
identify and address unmet needs. The Working Group will submit a 
report to the Secretary of HHS and Congress on issues related to tick-
borne diseases, including: Ongoing research: Advances in research: 
Federal activities; gaps in research; the Working Group's meetings; and 
the comments by the Working Group.
    Structure, Membership, and Operation: The Working Group consists of 
14 members selected to represent a diverse range of stakeholder 
perspectives. Seven members were nominated and selected from the 
public, and seven members, or their designees, represent federal 
agencies doing this work. A roster of Working Group members is 
available at the Working Group's Web page: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/index.html.

    Dated: November 15, 2017.
Richard Wolitski,
Director, Office of HIV/AIDS and Infectious Disease Policy, Designated 
Federal Officer, Tick-Borne Disease Working Group.
[FR Doc. 2017-25425 Filed 11-22-17; 8:45 am]
 BILLING CODE 4150-28-P